Emerging Biopharma

Biotech

Tubulis lands $63M to advance ADC pipeline led by Adcetris rival

Tubulis has raised $63 million to take forward ADCs based on technology to address the persistent toxicity problems facing the field.
Nick Paul Taylor May 3, 2022 5:00am

Layoff 'wave' not letting up amid oversaturation of biotechs

Mar 28, 2022 10:05am

Frazier's $987M fund geared toward new startups, spin outs

Mar 16, 2022 5:00am

Too many biotechs: It's time for 'musical chairs'

Mar 15, 2022 9:35am

Roche-partnered Scenic nabs $31M to test 3 rare disease meds

Mar 10, 2022 10:12am

Creyon collects $40M to create 'on demand' RNA-based medicines

Mar 8, 2022 10:00am
More News

Novartis backs 'Cinderella antibody' pitched as new drug class 

Mar 2, 2022 7:00am

Flagship's Vesalius emerges with $75M amid pharma partner hunt

Mar 2, 2022 6:00am

Ex-FDA interim head Giroir returns to biotech to make antivirals

Feb 11, 2022 10:00am

Septerna launches with $100M and GPCR pioneer co-founder

Jan 27, 2022 7:00am